TRANSLATIONAL STRATEGIES

What this means for you

This application is over — abandoned 04 Aug 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

98830622

Mark type

Stylized text

Filed

31 Oct 2024

Abandoned

04 Aug 2025

Attorney of record

David R. Schaffer

Goods and services

• Class 035 — Advertising and business services: Providing Business Consulting and Strategic Services; Business consulting services in the pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product industries
• Class 040 — Treatment of materials: Providing custom manufacturing services
• Class 041 — Education and entertainment services: Providing education, training, and workshop services, namely, conducting seminars and workshops in the fields of regulatory science, pharmaceuticals, biotechnology, drugs, chemicals, medical products, and consumer products; Training programs in regulatory science, pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product research methods
• Class 042 — Scientific and technological services: Providing online non-downloadable software and artificial intelligence (AI) tools for research and consulting; Non-downloadable software for pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product research and consulting; Non-downloadable computer modeling, simulation and artificial intelligence software tools for use in pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product research and development; Pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product development services; Consulting services, namely, product development research services in the fields of pharmaceutical, biotechnology, drug, chemical, medical products, and consumer products; Consulting services in the fields of pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product development research and development; Development and establishment of testing specifications and procedures for pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product industries; Development and establishment of testing specifications and procedures in the fields of pharmaceuticals, biotechnology, drugs, chemicals, medical products, and consumer products; Medical and scientific research in the fields of pharmaceutical, biotechnology, drug, chemical, medical products, and consumer products; Medical and scientific research and development using artificial intelligence in the fields of pharmaceutical, biotechnology, drug, chemical, medical products, and consumer products; Research and development in the fields of pharmaceutical, biotechnology, drug, chemical, medical products, and consumer products; Research and development using artificial intelligence in the fields of pharmaceutical, biotechnology, drug, chemical, medical products, and consumer products; Providing contract scientific research for others; Providing contract research in the pharmaceutical, drug, chemical, medical product, and consumer product industries for others
• Class 044 — Medical, beauty and agricultural services: Providing toxicity testing services, namely, testing of chemicals for others; Toxicity testing as part of the research and development of pharmaceutical, biotechnology, drug, chemical, medical, and consumer products
• Class 045 — Legal and security services: Providing regulatory consulting and legal compliance services; Providing regulatory consulting in the pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product industries; Toxicity testing of pharmaceutical, biotechnology, drug, chemical, medical, and consumer products for medical purposes

Owner

• Translational Cures, LLC, Wilmington, DE, US

Prosecution history

• 18 Aug 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 18 Aug 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 01 May 2025 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
• 01 May 2025 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
• 01 May 2025 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
• 01 May 2025 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
• 28 Apr 2025 — ASSIGNED TO EXAMINER
• 28 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 31 Oct 2024 — NEW APPLICATION ENTERED